Trial intelligence / Profile preview

Enteral Fish Oil vs UDCA and Placebo for Cholestasis in Infants

NCT02420496Phase 2Withdrawn

Sponsor
UT Health San Antonio
Start
Jun 2016
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fish oil concentrate in cholestasis, Parenteral Nutrition Associated Liver Disease (PNALD), sponsored by UT Health San Antonio. Planned start Jun 2016; status: withdrawn.

02

Drugs

fish oil concentrate
03

Conditions

cholestasisParenteral Nutrition Associated Liver Disease (PNALD)

Beyond the preview

Go deeper on NCT02420496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02420496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call